Lin S M, Chu Y C, Lur J Y, Lin S H, Hsiao H T, Lee T Y, Tsai S K
Department of Anesthesiology, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Acta Anaesthesiol Sin. 1998 Jun;36(2):75-80.
We investigated the neuromuscular effects of equipotent dose (3 x ED90) of mivacurium either given as a single bolus or under the influence of priming technique, comparing with that of succinylcholine in adults undergoing elective surgery during nitrous oxide-narcotic anesthesia.
Sixty ASA class I patients of either sex with age between 16 to 49 years were randomly assigned to 3 groups for a trial of mivacurium under nitrous oxide-narcotic anesthesia. Group I (non-priming group, n = 20) received mivacurium 0.25 mg/kg straight as a single intubating dose; Group II (priming group, n = 20) received an intubating dose of 0.225 mg/kg mivacurium which was preceded by 0.025 mg/kg 3 min earlier; and Group III received an intubating bolus of succinylcholine 1 mg/kg. Thenar electromyogram response to supramaximal train-of-four stimulation of the ulnar nerve at 12-s intervals was used to determine neuromuscular blockade. Blood pressure and heart rate were recorded before and at 1-min interval for 3 min after injection of drugs. Data were presented as mean +/- standard deviation. P value < 0.05 was considered statistically significant.
The onset time of mivacurium was accelerated by priming procedure in comparison with the nonpriming technique (2.0 min vs. 2.7 min), but it was much slower than that of succinylcholine (0.8 min). The priming procedure did not influence the duration of action or recovery. Side effects of mivacurium, such as cutaneous flushing and hypotension, were minimal at this dose in our patients.
Priming technique (with 10% of the total dose as the priming dose, and 3 min as the priming interval) can hasten the onset of mivacurium in adults during nitrous oxide-narcotic anesthesia without influencing the duration of action and recovery time.
我们研究了等效剂量(3×ED90)的米库氯铵以单次推注或预注技术给药时的神经肌肉效应,并与氧化亚氮 - 麻醉剂麻醉下接受择期手术的成人琥珀酰胆碱的效应进行比较。
60例年龄在16至49岁之间的ASA I级患者,男女不限,随机分为3组,在氧化亚氮 - 麻醉剂麻醉下进行米库氯铵试验。第一组(非预注组,n = 20)直接接受0.25 mg/kg米库氯铵作为单次插管剂量;第二组(预注组,n = 20)先在3分钟前接受0.025 mg/kg米库氯铵,随后接受0.225 mg/kg插管剂量;第三组接受1 mg/kg琥珀酰胆碱插管推注。使用对尺神经每隔12秒进行的超强四个成串刺激的鱼际肌电图反应来确定神经肌肉阻滞。在注射药物前和注射后3分钟内每隔1分钟记录血压和心率。数据以平均值±标准差表示。P值<0.05被认为具有统计学意义。
与非预注技术相比,预注程序加速了米库氯铵的起效时间(2.0分钟对2.7分钟),但比琥珀酰胆碱的起效时间(0.8分钟)慢得多。预注程序不影响作用持续时间或恢复。在我们的患者中,此剂量下米库氯铵的副作用,如皮肤潮红和低血压,最小。
预注技术(以总剂量的10%作为预注剂量,预注间隔为3分钟)可在氧化亚氮 - 麻醉剂麻醉期间加速成人米库氯铵的起效,而不影响作用持续时间和恢复时间。